Year: 2026
Type: article
Abstract: Dr. Tolkachjov is an investigator and speaker for CASTLE Biosciences, Kerecis, Boehringer Ingelheim, and Regeneron. No relevant conflicts of interest. The other authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
DOI: 10.1111/ijd.70324
Language: English
Topic: Cancer and Skin Lesions
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7127988294
